Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

Similar articles for PubMed (Select 21234673)

1.

β-Adrenergic receptors (β-AR) regulate VEGF and IL-6 production by divergent pathways in high β-AR-expressing breast cancer cell lines.

Madden KS, Szpunar MJ, Brown EB.

Breast Cancer Res Treat. 2011 Dec;130(3):747-58. doi: 10.1007/s10549-011-1348-y. Epub 2011 Jan 14.

2.

Activation of β2-adrenergic receptor by (R,R')-4'-methoxy-1-naphthylfenoterol inhibits proliferation and motility of melanoma cells.

Wnorowski A, Sadowska M, Paul RK, Singh NS, Boguszewska-Czubara A, Jimenez L, Abdelmohsen K, Toll L, Jozwiak K, Bernier M, Wainer IW.

Cell Signal. 2015 May;27(5):997-1007. doi: 10.1016/j.cellsig.2015.02.012. Epub 2015 Feb 20.

PMID:
25703025
3.

The effect of chronic stress on anti-angiogenesis of sunitinib in colorectal cancer models.

Liu J, Deng GH, Zhang J, Wang Y, Xia XY, Luo XM, Deng YT, He SS, Mao YY, Peng XC, Wei YQ, Jiang Y.

Psychoneuroendocrinology. 2015 Feb;52:130-42. doi: 10.1016/j.psyneuen.2014.11.008. Epub 2014 Nov 16.

PMID:
25437118
4.

Modeling of hypo/hyperglycemia and their impact on breast cancer progression related molecules.

Adham SA, Al Rawahi H, Habib S, Al Moundhri MS, Viloria-Petit A, Coomber BL.

PLoS One. 2014 Nov 17;9(11):e113103. doi: 10.1371/journal.pone.0113103. eCollection 2014.

5.

Differential β₂-adrenergic receptor expression defines the phenotype of non-tumorigenic and malignant human breast cell lines.

Gargiulo L, Copsel S, Rivero EM, Galés C, Sénard JM, Lüthy IA, Davio C, Bruzzone A.

Oncotarget. 2014 Oct 30;5(20):10058-69.

6.

Adrenergic signaling promotes angiogenesis through endothelial cell-tumor cell crosstalk.

Chen H, Liu D, Yang Z, Sun L, Deng Q, Yang S, Qian L, Guo L, Yu M, Hu M, Shi M, Guo N.

Endocr Relat Cancer. 2014 Oct;21(5):783-95. doi: 10.1530/ERC-14-0236.

PMID:
25179535
7.

Quercetin-3-O-glucuronide inhibits noradrenaline-promoted invasion of MDA-MB-231 human breast cancer cells by blocking β₂-adrenergic signaling.

Yamazaki S, Miyoshi N, Kawabata K, Yasuda M, Shimoi K.

Arch Biochem Biophys. 2014 Sep 1;557:18-27. doi: 10.1016/j.abb.2014.05.030. Epub 2014 Jun 11.

PMID:
24929186
8.

Biomarker identification in breast cancer: Beta-adrenergic receptor signaling and pathways to therapeutic response.

Kafetzopoulou LE, Boocock DJ, Dhondalay GK, Powe DG, Ball GR.

Comput Struct Biotechnol J. 2013 May 21;6:e201303003. doi: 10.5936/csbj.201303003. eCollection 2013.

9.

β-Blockers promote angiogenesis in the mouse aortic ring assay.

Stati T, Musumeci M, Maccari S, Massimi A, Corritore E, Strimpakos G, Pelosi E, Catalano L, Marano G.

J Cardiovasc Pharmacol. 2014 Jul;64(1):21-7. doi: 10.1097/FJC.0000000000000085.

PMID:
24621648
10.

Different effects of adenylyl cyclase activators and phosphodiesterases inhibitors on cervical cancer (HeLa) and breast cancer (MCF-7) cells proliferation.

Mahdian D, Shafiee-Nick R, Mousavi SH.

Toxicol Mech Methods. 2014 May;24(4):307-14. doi: 10.3109/15376516.2014.898354. Epub 2014 Mar 19.

PMID:
24593874
11.

Exogenous norepinephrine attenuates the efficacy of sunitinib in a mouse cancer model.

Deng GH, Liu J, Zhang J, Wang Y, Peng XC, Wei YQ, Jiang Y.

J Exp Clin Cancer Res. 2014 Feb 20;33:21. doi: 10.1186/1756-9966-33-21.

12.

Broad-scale phosphoprotein profiling of beta adrenergic receptor (β-AR) signaling reveals novel phosphorylation and dephosphorylation events.

Chruscinski AJ, Singh H, Chan SM, Utz PJ.

PLoS One. 2013 Dec 5;8(12):e82164. doi: 10.1371/journal.pone.0082164. eCollection 2013.

13.

The antidepressant desipramine and α2-adrenergic receptor activation promote breast tumor progression in association with altered collagen structure.

Szpunar MJ, Burke KA, Dawes RP, Brown EB, Madden KS.

Cancer Prev Res (Phila). 2013 Dec;6(12):1262-72. doi: 10.1158/1940-6207.CAPR-13-0079.

14.

Dosage-dependent regulation of cell proliferation and adhesion through dual β2-adrenergic receptor/cAMP signals.

Bruzzone A, Saulière A, Finana F, Sénard JM, Lüthy I, Galés C.

FASEB J. 2014 Mar;28(3):1342-54. doi: 10.1096/fj.13-239285. Epub 2013 Dec 5.

15.

Altered sympathetic-to-immune cell signaling via β₂-adrenergic receptors in adjuvant arthritis.

Lorton D, Bellinger DL, Schaller JA, Shewmaker E, Osredkar T, Lubahn C.

Clin Dev Immunol. 2013;2013:764395. doi: 10.1155/2013/764395. Epub 2013 Oct 1.

16.

β-Adrenergic system, a backstage manipulator regulating tumour progression and drug target in cancer therapy.

Tang J, Li Z, Lu L, Cho CH.

Semin Cancer Biol. 2013 Dec;23(6 Pt B):533-42. doi: 10.1016/j.semcancer.2013.08.009. Epub 2013 Sep 4. Review.

17.

The role of adrenergic signaling in breast cancer biology.

Obeid EI, Conzen SD.

Cancer Biomark. 2013;13(3):161-9. doi: 10.3233/CBM-130347. Review.

PMID:
23912488
18.

Src activation by β-adrenoreceptors is a key switch for tumour metastasis.

Armaiz-Pena GN, Allen JK, Cruz A, Stone RL, Nick AM, Lin YG, Han LY, Mangala LS, Villares GJ, Vivas-Mejia P, Rodriguez-Aguayo C, Nagaraja AS, Gharpure KM, Wu Z, English RD, Soman KV, Shahzad MM, Zigler M, Deavers MT, Zien A, Soldatos TG, Jackson DB, Wiktorowicz JE, Torres-Lugo M, Young T, De Geest K, Gallick GE, Bar-Eli M, Lopez-Berestein G, Cole SW, Lopez GE, Lutgendorf SK, Sood AK.

Nat Commun. 2013;4:1403. doi: 10.1038/ncomms2413. Erratum in: Nat Commun. 2013;4:1932. Shazhad, Mian M K [corrected to Shahzad, Mian M K].

19.

VEGF-C expression in oral cancer by neurotransmitter-induced activation of beta-adrenergic receptors.

Vilardi BM, Bravo-Calderón DM, Bernabé DG, Oliveira SH, Oliveira DT.

Tumour Biol. 2013 Feb;34(1):139-43. doi: 10.1007/s13277-012-0521-1. Epub 2012 Oct 12.

PMID:
23065569
20.

Mesenchymal stem cell-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migration.

De Luca A, Lamura L, Gallo M, Maffia V, Normanno N.

J Cell Biochem. 2012 Nov;113(11):3363-70. doi: 10.1002/jcb.24212.

PMID:
22644871
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk